Gly-βMCA modulates bile acid metabolism to reduce hepatobiliary injury in Mdr2 KO mice
{{output}}
Cholestasis results from impaired bile flow that causes hepatic bile acid accumulation and injury. Alleviating bile acid hepatobiliary toxicity is a major therapeutic goal in cholestasis. Our recent study revealed a potent anti-cholestasis effect of glycine-co... ...
